Afschin Soleiman
- Oncology top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Immunology top 10%
- Physiology top 5%
- Co-authors
- Dontscho KerjaschkiErnst KriehuberSilvana Breiteneder-GeleffKari AlitaloWolfgang WeningerErwin TschachlerGabriele AmannHeinrich Kowalski
- Topics
- Renal Transplantation Outcomes and Treatments (10 papers)Renal Diseases and Glomerulopathies (8 papers)Vasculitis and related conditions (8 papers)
- Cited by
- TransplantationOncologyNephrology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Experimental MedicineSHILAP Revista de lepidopterología
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Afschin Soleiman
55 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.6k
- Molecular Biology 986
- Surgery 915
- Immunology 408
- Physiology 397
Countries citing papers authored by Afschin Soleiman
This map shows the geographic impact of Afschin Soleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afschin Soleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afschin Soleiman more than expected).
Fields of papers citing papers by Afschin Soleiman
This network shows the impact of papers produced by Afschin Soleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afschin Soleiman. The network helps show where Afschin Soleiman may publish in the future.
Co-authorship network of co-authors of Afschin Soleiman
This figure shows the co-authorship network connecting the top 25 collaborators of Afschin Soleiman. A scholar is included among the top collaborators of Afschin Soleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afschin Soleiman. Afschin Soleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 16 | |
| 7 | 6 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 9 | |
| 11 | 57 | |
| 12 | 26 | |
| 13 | 9 | |
| 14 | 1 | |
| 15 | 22 | |
| 16 | Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer. | 25 |
| 17 | 30 | |
| 18 | 5 | |
| 19 | 42 | |
| 20 | Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillariesbreakdown → | 903 |
About Afschin Soleiman
Afschin Soleiman is a scholar working on Transplantation, Nephrology and Aging, having authored 56 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (10 papers), Renal Diseases and Glomerulopathies (8 papers) and Vasculitis and related conditions (8 papers). The work is most often cited by research in Transplantation (300 citations), Oncology (1.6k citations) and Nephrology (279 citations). Afschin Soleiman has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Dontscho Kerjaschki, Ernst Kriehuber, Silvana Breiteneder-Geleff, Kari Alitalo, Wolfgang Weninger, Erwin Tschachler, Gabriele Amann, Heinrich Kowalski, Sebastian F. Schoppmann and Dieter Maurer. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.